> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Modernization Act 3.0 Reintroduced
- URL: https://www.fdaweb.com/fda-modernization-act-3-0-reintroduced/
- Published: 2025-01-29T12:00:00.000Z
- Updated: 2026-09-14T14:51:56.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5158569

A bipartisan group of nine senators has reintroduced the FDA Modernization Act (FDAMA) 3.0 directing the agency to implement the FDA Modernization Act 2.0 legislation intended to modernize drug testing protocols and improve patient outcomes. A [statement](https://www.booker.senate.gov/news/press/booker-colleagues-reintroduce-fda-modernization-act-30?ref=fdaweb.com) issued by Sen. **Cory Booker** (D-NJ), one of the sponsors, says the bill is a bipartisan effort to reduce unnecessary animal testing while advancing scientific innovation. “By fully implementing FDAMA 2.0,” he says, “drug development can be both more humane and more efficient, ultimately leading to faster and more reliable treatments for patients. An astonishing 90-95% of drugs that pass animal tests go on to fail in human clinical trials, wasting precious time for patients.”

The statement says it has been over two years since Congress ended the statutory mandate that INDs undergo mandatory animal testing before human clinical trials. Booker says FDA cannot be allowed to continue to delay implementing the law. “If passed,” he says, “this bipartisan legislation will require FDA to finally update its regulations and will pave the way for more scientifically reliable and humane methods of drug development.”